Nasdaq:US$36.45 (-2.83) | HKEX:HK$60.55 (+0.00) | AIM:£5.37 (-0.28)
Search
EN
简
繁
About Us
Overview
Corporate Information
Board of Directors
Senior Management
Contact Us
What We Do
Overview
Research and Development
Commercialization
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Presentations
Recent News
Announcement & Press Releases
Presentations & Publications
Mailing List Sign-up
Shareholder Information
Overview
Events, Circulars & Forms
Share Price & Chart
Major Shareholders
Financial Reports & Filings
Analyst Coverage
Dual-listing FAQs
Information for Shareholders
Terms of Reference & Policies
Careers
About Us
Overview
Corporate Information
Board of Directors
Senior Management
Contact Us
What We Do
Overview
Research and Development
Commercialization
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Presentations
Recent News
Announcement & Press Releases
Presentations & Publications
Mailing List Sign-up
Shareholder Information
Overview
Events, Circulars & Forms
Share Price & Chart
Major Shareholders
Financial Reports & Filings
Analyst Coverage
Dual-listing FAQs
Information for Shareholders
Terms of Reference & Policies
Careers
Search Result
Chi-Med
Search Result
| Announcements & Press Releases
Previous Article
|
Next Article
Announcements & Press Releases
,
Oncology / Immunology
| 5 Nov 2009
Successful Global Phase IIb Ulcerative Colitis Trial for HMPL-004: All Primary and Secondary Endpoints Achieved Hutchison MediPharma Proceeding with Development and Partnership Plans
1 items
a091105